IDH1 mutation in prostate cancer: R132H and beyond von Flaherty, Amber Lea, Zhang, Jingsong, Teer, Jamie

Volltext

IDH1 mutation in prostate cancer: R132H and beyond von Flaherty, Amber Lea, Teer, Jamie, Zhang, Jingsong

Volltext

Clinical prognostic factors associated with outcome in renal cell cancer (RCC) patients with prior tyrosine kinase inhibitors or immunotherapy treated with everolimus von Amato, Robert J., Flaherty, Amber Lea, Zhang, Yufeng, Stepankiw, Mika

Volltext

Expression of PD-L1 in primary urothelial carcinoma (UC) von Zhang, Jingsong, Dickinson, Shohreh I, Clark, Noel D, Flaherty, Amber Lea

Volltext